Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3478270 | 0.88 | TSHR (0.35) | TSHRHPGD | |
| SCHEMBL3478417 | 0.87 | TSHR (0.33) | TSHRHPGD | |
| SCHEMBL1717354 | 0.87 | TSHR (0.38) | TSHRHPGD | |
| SCHEMBL5838035 | 0.83 | TSHR (0.35) | TSHRHPGD | |
| SCHEMBL3448578 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL5838713 | 0.81 | TSHR (0.34) | TSHRHPGD | |
| SCHEMBL11118154 | 0.80 | TSHR (0.37) | TSHRHPGD | |
| SCHEMBL18918481 | 0.80 | TSHR (0.37) | TSHRHPGD | |
| SCHEMBL110060 | 0.80 | TSHR (0.37) | TSHRHPGD | |
| SCHEMBL10430815 | 0.80 | TSHR (0.37) | TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4135623-B1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER | RXSIGHT INC (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260069403-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE | RXSIGHT, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20240252311-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER | RXSIGHT, INC. | 2024-08-01 | — | — | US | disclosed |
| EP-4294325-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE | RxSight, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-4135623-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER | RxSight, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| WO-2022177821-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE | RXSIGHT, INC. (US) | 2022-08-25 | — | — | WO | disclosed |
| US-20210322152-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER | RXSIGHT, INC. (US) | 2021-10-21 | — | — | US | disclosed |
| WO-2021211888-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER | RXSIGHT, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| US-20210251744-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE | RXSIGHT, INC. (US) | 2021-08-19 | — | — | US | disclosed |
| EP-2396355-B1 | COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS | VISIOGEN INC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-8680172-B2 | Copolymers for intraocular lens systems | VISIOGEN, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20130245756-A1 | COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS | LILLY MING INTERNATIONAL, INC. | 2013-09-19 | — | — | US | disclosed |
| US-8430928-B2 | Copolymers for intraocular lens systems | VISIOGEN, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20120245684-A1 | COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS | VISIOGEN, INC. (US) | 2012-09-27 | — | — | US | disclosed |
| US-8222360-B2 | Copolymers for intraocular lens systems | VISIOGEN, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20100211170-A1 | COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS | VISIOGEN, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| WO-2010093823-A2 | COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS | VISIOGEN, INC. (US) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069403-A1 | COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE | IGLV6-57, SMCHD1, UACA | TSHR 819/4885HPGD 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.